Editor's Picks

After a sluggish 2023, 2024 looks brighter for healthcare stocks. Numerous demographic and social factors also argue in favor of a long-term rise. What are the best healthcare stocks to buy...

Despite a challenging year with a stock price drop of over 41%, ACADIA Pharmaceuticals is seen by InvestingPro and Wall Street analysts as undervalued, with expectations of significant upside...

Today, we'll explore stocks offering promising dividends alongside potential growth opportunities and market favor. These stocks embody a coveted blend of strong dividends, promising earnings,...

As US index futures hint at a subdued start today amid lingering concerns about stretched valuations, especially on the S&P 500. Awaiting key data releases, investors remain watchful for any...

Central Banks had a big impact on gold and silver last week. Gold futures have made new highs - and traders should watch out for a potential correction because of PCE, GDP data. Meanwhile, silver...

Humana's stock has seen a 24% drop YTD due to slashed profit forecasts. Wall Street responded with analyst downgrades and lowered EPS expectations ahead of the Q1 report. Despite challenges,...

Walgreens' declining profits are fueling bearish sentiment. Can the new CEO orchestrate a turnaround? Meanwhile, the stock's downward trajectory persists. In 2024, invest like the big funds from the...

The fierce competition between Chinese EV giant BYD and US-based Tesla intensifies as the former has outpaced Tesla in key sales metrics. While Tesla faces production cuts amid BYD's aggressive...